Showing results (561-570 of 1,988) with videos related to
Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|July 29, 2023
Quality of information and appropriateness of ChatGPT outputs for urology patientsAndrea Cocci, Marta Pezzoli, Mattia Lo Re, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Multimodality radiotherapy and androgen ablation in the treatment of clinically localized prostate cancer: early results in high risk patientsT R Coblentz, E A Bissonette, K R Williams, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Can single dose preoperative intrathecal morphine sulfate provide cost-effective postoperative analgesia and patient satisfaction during radical prostatectomy in the current era of cost containment?J A Eandi, R W de Vere White, H S G R Tunuguntla, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
The value of patient-doctor dialog in the treatment of early prostate cancerR O Fourcade, P Mensink, B Ernemo, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Clinical significance of pulmonary metastases in stage D2 prostate cancer patientsH Nakamachi, H Suzuki, K Akakura, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?A V Kaisary, P Iversen, C J Tyrrell, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancerS Lehrer, E J Diamond, A M Bajwa, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Attitudes and use of alternative therapies in UK prostate cancer patients-isn't it time we were in the know?P J Cheetham, K J Le Monnier, S F BrewsterProstate Cancer and Prostatic Diseases|December 24, 2002
Comparative early results of the sandwich technique and transurethral electroresection in benign prostatic hyperplasiaH Perk, T A Serel, A Koşar, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
A quantitative analysis of the costs and benefits of prostate cancer screeningR M Benoit, H Grönberg, M J NaslundPageof 199